Radiopharm Theranostics logo

Radiopharm Theranostics

RADX | NASDAQ
Chart Builder DCF Calculator
$0.72
-$0.04 (-5.26%)
At close: Nov 16, 2026, 3:59 PM ET
$0.70
-$0.02 (-2.78%)
After-hours: Nov 16, 2026, 7:58 PM ET
-5.26%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
44.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #416/1021 (Top 41%)

Key Statistics

Market Data

Market Cap $930.08K
1D Range
0.72 0.81
52W Range
0.72 10.63

Valuation (TTM)

PE 0
PB 0.05
EV/EBITDA 0.04

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $6.00
Loading financial charts...

Profile

Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to a...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Dec 5, 2024
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Next Earnings
Feb 26, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+733.33%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.